Last reviewed · How we verify
NCT05102201
Effect of the Group-based Paro Intervention on Physiological and Psychological Outcomes
NA trial testing Paro (social robot) intervention in Dementia, Mild in 118 participants. Completed in 30 May 2022.
24 May 2022
Quick facts
| Lead sponsor | National Tainan Junior College of Nursing |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | health services research |
| Enrollment | 118 |
| Start date | 22 March 2022 |
| Primary completion | 24 May 2022 |
| Estimated completion | 30 May 2022 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Paro (social robot) intervention
Conditions studied
- Dementia, Mild — all drugs for Dementia, Mild →
- Dementia Moderate — all drugs for Dementia Moderate →
- Cognitive Impairment — all drugs for Cognitive Impairment →
Sponsor
National Tainan Junior College of Nursing
Who can join
65 and older, any sex, with Dementia, Mild or Dementia Moderate. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project contains three studies. This study will use a pilot randomized controlled trial to examine the effect of Paro (social robot) intervention on oxytocin, dopamine, and HRV variations and mental well-being for specific attachment older adults with dementia. A randomized controlled trial, single-blind, two parallel groups, and repeated measures design were used to examine the effects of Paro intervention on neurobiologically changes and mental well-being for specific attachment older adults with dementia before, during, and after the intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05102201
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dementia, Mild
Currently open trials in the same condition.
- NCT07083154 — GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study) · Phase 3 · recruiting
- NCT06854718 — Pain With Dementia · NA · recruiting
- NCT06928298 — Cognitive Screening Made Easy for PCPs - Administrative Supplement · NA · recruiting
- NCT06584110 — Buddy-Up Dyadic Physical Activity Program for Persons With Dementia and Family Caregivers · NA · recruiting
- NCT06444841 — Paper-Based and Smartphone-Based Memory Supports · NA · recruiting
Other National Tainan Junior College of Nursing trials
Trials by the same sponsor.
- NCT06606600 — Impacts of Kebbi Robot Intervention for Older Adults With Mild Dementia · NA · recruiting
- NCT05957861 — Exploring the Effectiveness to Web-based Exercise Among Community-dwelling Adults With High Body Fat · NA · completed
- NCT05949710 — Explore the Relationship Between Heart Rate Variability, Body Mass Index, Inflammation, and Insulin Resistance. · NA · completed
- NCT05580263 — Different Order of Concurrent Training on Improving Visceral Adipose Tissue and Insulin Resistance. · NA · completed
- NCT05215275 — Comparison of Different Exercise Trainings on Heart Rate Variability · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05102201 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Tainan Junior College of Nursing
- Last refreshed: 28 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05102201.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing